Sign in

Gartner, Inc. IT

Price 195.5 USD
as of 2026-09-05
59/100
Weak
Quality76
Growth24
Balance-sheet strength71
Valuation69
Momentum42
Income50

Composite 59/100; the shares have moved about 60% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 24/100 — a strong mark against it.

Case for

Quality ranks 76/100 — a strong point in its favour. Balance-sheet strength ranks 71/100 — a moderate point in its favour. Valuation ranks 69/100 — a moderate point in its favour.

Case against

Growth ranks 24/100 — a strong mark against it. Momentum ranks 42/100 — a slight mark against it.

What the company does Gartner provides business and technology insights via subscription research, conferences, and consulting to support mission-critical decision-making for enterprises globally.

Key financials Gross margin 69.6%, operating margin 22.6%, net margin 12.0%. ROE 113.6%, ROA 10.2%, ROCE 31.6%. Revenue growth 3.7%, EPS growth -36.8%. Debt/Equity -17.80, net debt/EBITDA 1.33, interest coverage 14.16.

Stock health Sideravia scores: Quality 78.8 (strong), Valuation 63.7 (attractive), Momentum 34.8 (weak). Piotroski F-Score 5/9, Altman Z 3.67. RSI(14) 68.40 indicates overbought conditions.

Price vs fair value The stock trades at a PREMIUM of 5.20% versus the analyst mean target of 185.77. - FactSet highlights a 58% 6-month jump (Zacks, 2026-08-21) - Simply Wall St notes undervaluation after a 43% 3-year slump (2026-08-20) - Zacks flags Gartner among high ROE stocks amid volatility (2026-08-21)

Looking forward Forward P/E 13.68 and PEG 0.72 suggest attractive relative valuation, but EPS growth remains negative at -36.8%. Consulting demand and research subscriptions drive long-term stability.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.